机译:韩国人的四个新的等位基因,HLA-B * 40:323 HLA-B * 40:323,DRB1 * 14:177 DRB1 * 14:177,DQB1 * 03:200 DQB1 * 03:200和DQB1 * 06:205 DQB1 * 06:205
Department of Laboratory MedicineUniversity of Ulsan College of Medicine and Asan Medical;
Department of Laboratory MedicineUniversity of Ulsan College of Medicine and Asan Medical;
Biowithus Life Science InstituteSeoul South Korea;
Biowithus Life Science InstituteSeoul South Korea;
Department of Laboratory MedicineUniversity of Ulsan College of Medicine and Asan Medical;
HLA‐B*40:323; HLA‐DRB1*14:177; HLA‐DQB1*03:200; HLA‐DQB1*06:205;
机译:韩国人的四个新的等位基因,HLA-B * 40:323 HLA-B * 40:323,DRB1 * 14:177 DRB1 * 14:177,DQB1 * 03:200 DQB1 * 03:200和DQB1 * 06:205 DQB1 * 06:205
机译:三种新型HLA II类等位基因的免疫遗传学:DRB1 * 03:112,DQB1 * 03:02:16和DQB1 * 03:139
机译:从Nagaland,Nangalland,印度东北部的AO个体中检测新的HLA-DQB1 * 03:404 HLA-DQB1 * 03:404等位基因
机译:日语中的人类白细胞抗原和全身性硬化症:四个独立保护性等位基因的标志DRB1 * 13:02DRB1 * 14:06DQB1 * 03:01和DPB1 * 02:01
机译:日语中的人类白细胞抗原和系统性硬化症:四个独立保护性等位基因的标志DRB1 * 13:02,DRB1 * 14:06,DQB1 * 03:01和DPB1 * 02:01